These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 20582905)
1. Analgesic use and the risk for progression of chronic kidney disease. Kuo HW; Tsai SS; Tiao MM; Liu YC; Lee IM; Yang CY Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):745-51. PubMed ID: 20582905 [TBL] [Abstract][Full Text] [Related]
3. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study. Rahme E; Nedjar H Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults. Huang WF; Hsiao FY; Wen YW; Tsai YW Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003 [TBL] [Abstract][Full Text] [Related]
5. Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs. Castellsague J; Holick CN; Hoffman CC; Gimeno V; Stang MR; Perez-Gutthann S Pharmacotherapy; 2009 Dec; 29(12):1397-407. PubMed ID: 19947799 [TBL] [Abstract][Full Text] [Related]
7. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study. Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567 [TBL] [Abstract][Full Text] [Related]
8. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis. Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070 [TBL] [Abstract][Full Text] [Related]
10. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease. Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications. Velentgas P; West W; Cannuscio CC; Watson DJ; Walker AM Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):641-52. PubMed ID: 16392153 [TBL] [Abstract][Full Text] [Related]
12. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study. Rahme E; Nedjar H; Bizzi A; Morin S Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525 [TBL] [Abstract][Full Text] [Related]
13. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan. Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830 [TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism. Biere-Rafi S; Di Nisio M; Gerdes V; Porreca E; Souverein P; Boer A; Büller H; Kamphuisen P Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):635-42. PubMed ID: 21462279 [TBL] [Abstract][Full Text] [Related]
15. NSAID use and progression of chronic kidney disease. Gooch K; Culleton BF; Manns BJ; Zhang J; Alfonso H; Tonelli M; Frank C; Klarenbach S; Hemmelgarn BR Am J Med; 2007 Mar; 120(3):280.e1-7. PubMed ID: 17349452 [TBL] [Abstract][Full Text] [Related]
16. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study. Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481 [TBL] [Abstract][Full Text] [Related]
18. Lifetime nonnarcotic analgesic use and decline in renal function in women. Curhan GC; Knight EL; Rosner B; Hankinson SE; Stampfer MJ Arch Intern Med; 2004 Jul; 164(14):1519-24. PubMed ID: 15277282 [TBL] [Abstract][Full Text] [Related]
19. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study. Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699 [TBL] [Abstract][Full Text] [Related]
20. Use and abuse of analgesics in Nigeria: a community survey. Agaba EI; Agaba PA; Wigwe CM Niger J Med; 2004; 13(4):379-82. PubMed ID: 15523865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]